HLA Typing for Transplant Market Trends

Growth Drivers

• Rising volumes of organ transplantations: There is a surge in the number of individuals opting for organ transplantation, which will lead to a surge in the demand for HLA typing for transplant market. As per a WHO report published in 2024, the number of organ transplant procedures reached more than 140,000 in a year. Besides the developing countries such as India and Brazil are expanding their transplant infrastructure, thereby increasing the necessity for HLA testing, denoting a positive market outlook.
• Diagnostic advancements: The ongoing proceedings in precision diagnostics significantly drive business in the HLA typing for transplant market. NIH in 2023 reported that next-generation sequencing and PCR-based HLA typing are capturing above 62% of the market share, appreciably lowering graft rejection rates by 35%. Besides the U.S. FDA, it fast-tracked five new HLA assays, reflecting the growing adoption. Additionally, a clinical study by AHRQ in 2022 found that NGS-based typing saves hospital stays by 20%, saving $500 million annually in monitoring after transplantation, thus uplifting market expansion.

Historical Patient Growth and Its Impact on HLA Typing for Transplant Market Expansion

The global HLA typing for transplant market is gaining traction, owing to its large patient pool. Moreover, there is a fast-rising prevalence of renal disease, hematologic cancers, and solid organ failures across all nations.  This high consumer base directly correlates with today’s growing industry as transplant centers necessitate higher precise and matching solutions. Furthermore, it is reported that countries with aging populations, such as Japan and Germany, saw accelerated demand for kidney and bone marrow transplants, similarly, India and China witnessed growth due to rising ESRD cases.

The data below highlights country-specific patient growth from 2010 to 2020:

Feasible Expansion Models Shaping the Future of HLA Typing for Transplant Market

The global HLA typing for transplant market is gaining immense exposure, shaped by numerous tactical expansion models. Key trends opted by the global players to enhance their ecosystem include domestic collaborations, automation scaling, and AI-based accurate diagnostics. In this regard WHO in 2024 reported that suppliers based in India collaborated with domestic healthcare facilities and witnessed a substantial increase in revenue by 14% from 2022 to 2024, opting for affordable costs. Besides, the developed nations, such as the U.S. and the EU, are adopting subscription-based allele databases, with NIH declaring a $95 million annual revenue growth. Therefore, these expansion models are anticipated to boost the market growth.

Feasibility Models for HLA Typing Market Expansion

Challenge

• High costs of advanced equipment: One of the restricting factors in the HLA typing for transplant market is the high costs associated with this advanced equipment. In this regard, MoHFW in 2024 reported that in developing nations such as India, patients undergoing transplantation are paying more than USD 1,000 for HLA typing, which restricts the adoption among people from price-sensitive regions. Besides, in Brazil, SUS covers only 35% of tests, reflecting the healthcare disparities. Therefore, these expenses mark a considerable hurdle in the market, restricting optimum consumer base adoption.